75 related articles for article (PubMed ID: 22858585)
1. Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA.
Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Kobayashi N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
J Thorac Oncol; 2012 Sep; 7(9):1369-81. PubMed ID: 22858585
[TBL] [Abstract][Full Text] [Related]
2. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
3. Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).
Takahama T; Sakai K; Takeda M; Azuma K; Hida T; Hirabayashi M; Oguri T; Tanaka H; Ebi N; Sawa T; Bessho A; Tachihara M; Akamatsu H; Bandoh S; Himeji D; Ohira T; Shimokawa M; Nakanishi Y; Nakagawa K; Nishio K
Oncotarget; 2016 Sep; 7(36):58492-58499. PubMed ID: 27542267
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.
Oxnard GR; Paweletz CP; Kuang Y; Mach SL; O'Connell A; Messineo MM; Luke JJ; Butaney M; Kirschmeier P; Jackman DM; Jänne PA
Clin Cancer Res; 2014 Mar; 20(6):1698-1705. PubMed ID: 24429876
[TBL] [Abstract][Full Text] [Related]
5. Comparison of droplet digital PCR and conventional quantitative PCR for measuring
Zhang BO; Xu CW; Shao Y; Wang HT; Wu YF; Song YY; Li XB; Zhang Z; Wang WJ; Li LQ; Cai CL
Exp Ther Med; 2015 Apr; 9(4):1383-1388. PubMed ID: 25780439
[TBL] [Abstract][Full Text] [Related]
6. EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.
Thress KS; Brant R; Carr TH; Dearden S; Jenkins S; Brown H; Hammett T; Cantarini M; Barrett JC
Lung Cancer; 2015 Dec; 90(3):509-15. PubMed ID: 26494259
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.
Uchida J; Kato K; Kukita Y; Kumagai T; Nishino K; Daga H; Nagatomo I; Inoue T; Kimura M; Oba S; Ito Y; Takeda K; Imamura F
Clin Chem; 2015 Sep; 61(9):1191-6. PubMed ID: 26206882
[TBL] [Abstract][Full Text] [Related]
8. Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.
Watanabe M; Kawaguchi T; Isa S; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kakegawa S; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Sakamoto K; Matsumura A; Koh Y
Clin Cancer Res; 2015 Aug; 21(15):3552-60. PubMed ID: 25882755
[TBL] [Abstract][Full Text] [Related]
9. Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.
Mok T; Wu YL; Lee JS; Yu CJ; Sriuranpong V; Sandoval-Tan J; Ladrera G; Thongprasert S; Srimuninnimit V; Liao M; Zhu Y; Zhou C; Fuerte F; Margono B; Wen W; Tsai J; Truman M; Klughammer B; Shames DS; Wu L
Clin Cancer Res; 2015 Jul; 21(14):3196-203. PubMed ID: 25829397
[TBL] [Abstract][Full Text] [Related]
10. Quantification of concentration and assessment of EGFR mutation in circulating DNA.
Mazurek A; Pierzyna M; Giglok M; Dworzecka U; Suwiński R; Ma Usecka E
Cancer Biomark; 2015; 15(4):515-24. PubMed ID: 25769456
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsies: genotyping circulating tumor DNA.
Diaz LA; Bardelli A
J Clin Oncol; 2014 Feb; 32(6):579-86. PubMed ID: 24449238
[TBL] [Abstract][Full Text] [Related]
12. Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.
Zhu G; Ye X; Dong Z; Lu YC; Sun Y; Liu Y; McCormack R; Gu Y; Liu X
J Mol Diagn; 2015 May; 17(3):265-72. PubMed ID: 25769900
[TBL] [Abstract][Full Text] [Related]
13. Correlation between plasma DNA and tumor status in an animal model.
Sueoka-Aragane N; Sato A; Kobayashi N; Ide M; Yokoo M; Nagano Y; Sueoka E; Okada S; Kimura S
PLoS One; 2014; 9(12):e111881. PubMed ID: 25462870
[TBL] [Abstract][Full Text] [Related]
14. EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.
Hubers AJ; Heideman DA; Yatabe Y; Wood MD; Tull J; Tarón M; Molina MA; Mayo C; Bertran-Alamillo J; Herder GJ; Koning R; Sie D; Ylstra B; Meijer GA; Snijders PJ; Witte BI; Postmus PE; Smit EF; Thunnissen E
Lung Cancer; 2013 Oct; 82(1):38-43. PubMed ID: 23927883
[TBL] [Abstract][Full Text] [Related]
15. Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib.
Nakamura T; Sato A; Nakashima C; Abe T; Iwanaga K; Umeguchi H; Kawaguchi A; Sueoka-Aragane N
Cancer Sci; 2023 Mar; 114(3):1045-1055. PubMed ID: 36382532
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy.
Boonstra PA; Wind TT; van Kruchten M; Schuuring E; Hospers GAP; van der Wekken AJ; de Groot DJ; Schröder CP; Fehrmann RSN; Reyners AKL
Cancer Metastasis Rev; 2020 Sep; 39(3):999-1013. PubMed ID: 32367253
[TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.
Rijavec E; Coco S; Genova C; Rossi G; Longo L; Grossi F
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861557
[TBL] [Abstract][Full Text] [Related]
18. Circulating biomarkers in patients with glioblastoma.
Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
[TBL] [Abstract][Full Text] [Related]
19. Applications of liquid biopsy in lung cancer-diagnosis, prognosis prediction, and disease monitoring.
Luo W; Rao M; Qu J; Luo D
Am J Transl Res; 2018; 10(12):3911-3923. PubMed ID: 30662639
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
